Related Experiment Video
Updated: Apr 26, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Effectiveness of maternal pertussis vaccination in England: an observational study
Gayatri Amirthalingam1, Nick Andrews2, Helen Campbell1
1Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, UK.
Insights
The pertussis vaccination program for pregnant women in England demonstrated high vaccine effectiveness, significantly reducing infant cases and hospitalizations. This maternal immunization strategy offers crucial protection for newborns against pertussis.
Area of Science:
- Immunology
- Public Health
- Epidemiology
Background:
- England introduced a pertussis (whooping cough) vaccination program for pregnant women in October 2012.
- This initiative was a direct response to a pertussis outbreak across England.
- The study aimed to evaluate the effectiveness of this vaccination program in preventing infant pertussis.
Purpose of the Study:
- To assess the vaccine effectiveness of maternal pertussis immunization.
- To determine the overall impact of the vaccination program on infant pertussis incidence and hospitalizations.
- To provide data for international policymakers regarding maternal vaccination strategies.
Main Methods:
- Analysis of laboratory-confirmed pertussis cases and hospital admissions in infants (January 2008–September 2013).
- Data sourced from Public Health England's enhanced pertussis surveillance.
- Vaccine effectiveness calculated by comparing maternal vaccination status in confirmed infant cases against national vaccine coverage data (Clinical Practice Research Datalink).
Main Results:
- A significant decline in pertussis cases and hospitalizations was observed following the program's introduction, particularly in infants under 3 months.
- Infants under 3 months experienced a 78% reduction in confirmed cases and a 68% reduction in hospitalizations in the first 9 months of 2013 compared to 2012.
- Maternal vaccine coverage reached 64%, with calculated vaccine effectiveness of 91% for infants under 3 months and 90% for infants under 2 months.
Conclusions:
- The maternal pertussis vaccination program in England is associated with high vaccine effectiveness.
- Infant protection is likely achieved through both passive antibody transfer from mothers and reduced maternal exposure to pertussis.
- The findings offer valuable insights for global public health strategies concerning pertussis prevention in infants.
Background:
In October, 2012, a pertussis vaccination programme for pregnant women was introduced in response to an outbreak across England. We aimed to assess the vaccine effectiveness and the overall effect of the vaccine programme in preventing pertussis in infants.
Methods:
We undertook an analysis of laboratory-confirmed cases and hospital admissions for pertussis in infants between Jan 1, 2008, and Sept 30, 2013, using data submitted to Public Health England as part of its enhanced surveillance of pertussis in England, to investigate the effect of the vaccination programme. We calculated vaccine effectiveness by comparing vaccination status for mothers in confirmed cases with estimates of vaccine coverage for the national population of pregnant women, based on data from the Clinical Practice Research Datalink.
Findings:
The monthly total of confirmed cases peaked in October, 2012 (1565 cases), and subsequently fell across all age groups. For the first 9 months of 2013 compared with the same period in 2012, the greatest proportionate fall in confirmed cases (328 cases in 2012 vs 72 cases in 2013, -78%, 95% CI -72 to -83) and in hospitalisation admissions (440 admissions in 2012 vs 140 admissions in 2013, -68%, -61 to -74) occurred in infants younger than 3 months, although the incidence remained highest in this age group. Infants younger than 3 months were also the only age group in which there were fewer cases in 2013 than in 2011 (118 cases in 2011 vs 72 cases in 2013), before the resurgence. 26?684 women included in the Clinical Practice Research Datalink had a livebirth between Oct 1, 2012 and Sept 3, 2013; the average vaccine coverage before delivery based on this cohort was 64%. Vaccine effectiveness based on 82 confirmed cases in infants born from Oct 1, 2012, and younger than 3 months at onset was 91% (95% CI 84 to 95). Vaccine effectiveness was 90% (95% CI 82 to 95) when the analysis was restricted to cases in children younger than 2 months.
Interpretation:
Our assessment of the programme of pertussis vaccination in pregnancy in England is consistent with high vaccine effectiveness. This effectiveness probably results from protection of infants by both passive antibodies and reduced maternal exposure, and will provide valuable information to international policy makers.
Funding:
Public Health England.
Related Concept Videos
Vaccinations
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Development of the Oral Microbiota

